Literature DB >> 29844171

Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.

Géza Berecki1, Katherine B Howell2,3,4, Yadeesha H Deerasooriya5, Maria Roberta Cilio6,7, Megan K Oliva8, David Kaplan8, Ingrid E Scheffer8,2,3,9, Samuel F Berkovic9, Steven Petrou1,10,11,12.   

Abstract

De novo variants in SCN2A developmental and epileptic encephalopathy (DEE) show distinctive genotype-phenotype correlations. The two most recurrent SCN2A variants in DEE, R1882Q and R853Q, are associated with different ages and seizure types at onset. R1882Q presents on day 1 of life with focal seizures, while infantile spasms is the dominant seizure type seen in R853Q cases, presenting at a median age of 8 months. Voltage clamp, which characterizes the functional properties of ion channels, predicted gain-of-function for R1882Q and loss-of-function for R853Q. Dynamic action potential clamp, that we implement here as a method for modeling neurophysiological consequences of a given epilepsy variant, predicted that the R1882Q variant would cause a dramatic increase in firing, whereas the R853Q variant would cause a marked reduction in action potential firing. Dynamic clamp was also able to functionally separate the L1563V variant, seen in benign familial neonatal-infantile seizures from R1882Q, seen in DEE, suggesting a diagnostic potential for this type of analysis. Overall, the study shows a strong correlation between clinical phenotype, SCN2A genotype, and functional modeling. Dynamic clamp is well positioned to impact our understanding of pathomechanisms and for development of disease mechanism-targeted therapies in genetic epilepsy.

Entities:  

Keywords:  de novo SCN2A mutation; dynamic action potential clamp; epilepsy; modeling; voltage clamp

Mesh:

Substances:

Year:  2018        PMID: 29844171      PMCID: PMC6004444          DOI: 10.1073/pnas.1800077115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A quantitative description of membrane current and its application to conduction and excitation in nerve.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

2.  HERG channel (dys)function revealed by dynamic action potential clamp technique.

Authors:  Géza Berecki; Jan G Zegers; Arie O Verkerk; Zahurul A Bhuiyan; Berend de Jonge; Marieke W Veldkamp; Ronald Wilders; Antoni C G van Ginneken
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

3.  SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.

Authors:  Katherine B Howell; Jacinta M McMahon; Gemma L Carvill; Dimira Tambunan; Mark T Mackay; Victoria Rodriguez-Casero; Richard Webster; Damian Clark; Jeremy L Freeman; Sophie Calvert; Heather E Olson; Simone Mandelstam; Annapurna Poduri; Heather C Mefford; A Simon Harvey; Ingrid E Scheffer
Journal:  Neurology       Date:  2015-08-19       Impact factor: 9.910

4.  Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.

Authors:  Géza Berecki; Jan G Zegers; Zahurul A Bhuiyan; Arie O Verkerk; Ronald Wilders; Antoni C G van Ginneken
Journal:  J Physiol       Date:  2005-10-27       Impact factor: 5.182

5.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Authors:  Ingrid E Scheffer; Samuel Berkovic; Giuseppe Capovilla; Mary B Connolly; Jacqueline French; Laura Guilhoto; Edouard Hirsch; Satish Jain; Gary W Mathern; Solomon L Moshé; Douglas R Nordli; Emilio Perucca; Torbjörn Tomson; Samuel Wiebe; Yue-Hua Zhang; Sameer M Zuberi
Journal:  Epilepsia       Date:  2017-03-08       Impact factor: 5.864

6.  Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures.

Authors:  Roy Ben-Shalom; Caroline M Keeshen; Kiara N Berrios; Joon Y An; Stephan J Sanders; Kevin J Bender
Journal:  Biol Psychiatry       Date:  2017-01-27       Impact factor: 13.382

7.  Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome.

Authors:  Kazuyuki Nakamura; Mitsuhiro Kato; Hitoshi Osaka; Sumimasa Yamashita; Eiji Nakagawa; Kazuhiro Haginoya; Jun Tohyama; Mitsuko Okuda; Takahito Wada; Shuichi Shimakawa; Katsumi Imai; Saoko Takeshita; Hisako Ishiwata; Dorit Lev; Tally Lerman-Sagie; David E Cervantes-Barragán; Camilo E Villarroel; Masaharu Ohfu; Karin Writzl; Barbara Gnidovec Strazisar; Shinichi Hirabayashi; David Chitayat; Diane Myles Reid; Kiyomi Nishiyama; Hirofumi Kodera; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Kiyoshi Hayasaka; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

8.  Patterns and rates of exonic de novo mutations in autism spectrum disorders.

Authors:  Benjamin M Neale; Yan Kou; Li Liu; Avi Ma'ayan; Kaitlin E Samocha; Aniko Sabo; Chiao-Feng Lin; Christine Stevens; Li-San Wang; Vladimir Makarov; Paz Polak; Seungtai Yoon; Jared Maguire; Emily L Crawford; Nicholas G Campbell; Evan T Geller; Otto Valladares; Chad Schafer; Han Liu; Tuo Zhao; Guiqing Cai; Jayon Lihm; Ruth Dannenfelser; Omar Jabado; Zuleyma Peralta; Uma Nagaswamy; Donna Muzny; Jeffrey G Reid; Irene Newsham; Yuanqing Wu; Lora Lewis; Yi Han; Benjamin F Voight; Elaine Lim; Elizabeth Rossin; Andrew Kirby; Jason Flannick; Menachem Fromer; Khalid Shakir; Tim Fennell; Kiran Garimella; Eric Banks; Ryan Poplin; Stacey Gabriel; Mark DePristo; Jack R Wimbish; Braden E Boone; Shawn E Levy; Catalina Betancur; Shamil Sunyaev; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Bernie Devlin; Richard A Gibbs; Kathryn Roeder; Gerard D Schellenberg; James S Sutcliffe; Mark J Daly
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

9.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

10.  Generation of Functional Inhibitory Synapses Incorporating Defined Combinations of GABA(A) or Glycine Receptor Subunits.

Authors:  Christine L Dixon; Yan Zhang; Joseph W Lynch
Journal:  Front Mol Neurosci       Date:  2015-12-23       Impact factor: 5.639

View more
  22 in total

1.  Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.

Authors:  Melody Li; Nikola Jancovski; Paymaan Jafar-Nejad; Lisseth E Burbano; Ben Rollo; Kay Richards; Lisa Drew; Alicia Sedo; Jacqueline Heighway; Svenja Pachernegg; Armand Soriano; Linghan Jia; Todd Blackburn; Blaine Roberts; Alex Nemiroff; Kelley Dalby; Snezana Maljevic; Christopher A Reid; Frank Rigo; Steven Petrou
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

2.  SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.

Authors:  Qian-Bei Guo; Li Zhan; Hai-Yan Xu; Zhao-Bing Gao; Yue-Ming Zheng
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

Review 3.  Rational Small Molecule Treatment for Genetic Epilepsies.

Authors:  Ethan M Goldberg
Journal:  Neurotherapeutics       Date:  2021-08-24       Impact factor: 6.088

4.  Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.

Authors:  Zhefu Que; Maria I Olivero-Acosta; Jingliang Zhang; Muriel Eaton; Anke M Tukker; Xiaoling Chen; Jiaxiang Wu; Junkai Xie; Tiange Xiao; Kyle Wettschurack; Layan Yunis; J Marshall Shafer; James A Schaber; Jean-Christophe Rochet; Aaron B Bowman; Chongli Yuan; Zhuo Huang; Chang-Deng Hu; Darci J Trader; William C Skarnes; Yang Yang
Journal:  J Neurosci       Date:  2021-10-29       Impact factor: 6.709

5.  Functional analysis of three Nav1.6 mutations causing early infantile epileptic encephalopathy.

Authors:  Laura Solé; Jacy L Wagnon; Michael M Tamkun
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-08       Impact factor: 5.187

Review 6.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

7.  [Effect of calmodulin and its mutants on binding to NaV1.2 IQ].

Authors:  Yujun Wan; Junyan Liu; Yuting Wang; Xiaoyu Cheng; Sha Sha; Wanying Jia; Delin Hu; Xinyu Li; Feng Guo
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

8.  Differential Functional Changes of Nav1.2 Channel Causing SCN2A-Related Epilepsy and Status Epilepticus During Slow Sleep.

Authors:  Pu Miao; Siyang Tang; Jia Ye; Jihong Tang; Jianda Wang; Chaoguang Zheng; Yuezhou Li; Jianhua Feng
Journal:  Front Neurol       Date:  2021-05-19       Impact factor: 4.003

9.  Gastrointestinal Symptoms and Channelopathy-Associated Epilepsy.

Authors:  Veronica C Beck; Lori L Isom; Anne T Berg
Journal:  J Pediatr       Date:  2021-06-26       Impact factor: 6.314

10.  Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy.

Authors:  Surobhi Ganguly; Christopher H Thompson; Alfred L George
Journal:  J Physiol       Date:  2021-08-09       Impact factor: 6.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.